Gustavo Ballvé on July 26th, 2016

An update to last week’s post with two reading lists can only mean one thing… more books! These lists are wide-ranging in nature, coming from TED speakers and Farnam Street Blog members, a multidisciplinarian crowd if there ever was any. Enjoy!

Read more about Reading lists: an update

Gustavo Ballvé on July 21st, 2016

An (unnecessary) debate has begun about the right of Board members to access data in excess of what management provides, if necessary. We can and should discuss the form of potential abuses and its punishments, as well as reasonable boundaries of access to management and data. But we should not seek to remove a basic right of the Board members, who are personally liable for their decisions.

Read more about Overkill – basic Board member rights threatened

Gustavo Ballvé on July 19th, 2016

Shamelessly I return to reading lists, one from McKinsey & Co. and the other from Harvard Business School. If you don’t know whether to thank me or hate me (“I haven’t finished the last books I bought and here comes an interesting list…”), I completely understand you.

Read more about Reading lists – CEOs and HBS professors

Gustavo Ballvé on July 7th, 2016

Two noteworthy articles and one notable initiative in Brazilian CG practices nowadays. One regards an already-missed opportunity, the others still have potential (but should be treated with priority by investors interested in improving Brazilian capital markets).

Read more about Chances (blown?) for CG improvement in Brazil

Gustavo Ballvé on July 6th, 2016

Bill Gates wrote a very touching note on the 25th anniversary of his friendship with Warren Buffett. As he points out, he had no idea they would become such friends given their different backgrounds. The lesson here, if there is any, is to be truly humble – intellectually and personally.

Read more about An amazing friendship: Buffett and Gates

Gustavo Ballvé on July 1st, 2016

After a very public fraud issue with insurance licensing, Zenefits is taking steps to re-adequate its financing and shareholder base. Yes, it is in exchange for a promise of no legal action, and no, not everyone is happy – but it seems as interesting as it is unusual.

Read more about Unusual steps at Zenefits

Back to top